The expression of PD-1 ligands and IDO1 by macrophage/microglia in primary central nervous system lymphoma
Authors:
- Yuko MiyasatoYMYuko Miyasato
- Yasuo TakashimaYTYasuo Takashima
- Hiroto TakeyaHTHiroto Takeya
- Hiromu YanoHYHiromu Yano
- Azusa HayanoAHAzusa Hayano
- Takenobu NakagawaTNTakenobu Nakagawa
- Keishi MakinoKMKeishi Makino
- Motohiro TakeyaMTMotohiro Takeya
- Ryuya YamanakaRyuya Yamanaka
- Yoshihiro KomoharaYoshihiro Komohara
- 1 January 2018
- journal article
- research article
- Published by Japanese Society for Lymphoreticular Tissue Research in Journal of Clinical and Experimental Hematopathology
- Vol. 58 (2) , 95-101
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 29 references indexed in Scilit:
- An increase in indoleamine 2,3-dioxygenase-positive cells in the tumor microenvironment predicts favorable prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisoloneLeukemia & Lymphoma, 2016
- Tumor‐Associated Macrophages Associate with Cerebrospinal Fluid Interleukin‐10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)Brain Pathology, 2015
- Inhibition of indoleamine 2,3‐dioxygenase 1 expression alters immune response in colon tumor microenvironment in miceCancer Science, 2015
- Trial watch: IDO inhibitors in cancer therapyOncoImmunology, 2014
- Clinical significance of macrophage heterogeneity in human malignant tumorsCancer Science, 2013
- Clinical significance of CD163+ tumor‐associated macrophages in patients with adult T‐cell leukemia/lymphomaCancer Science, 2013
- Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System LymphomaClinical Cancer Research, 2012
- Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)Neuro-Oncology, 2011
- Management of refractory or relapsed primary central nervous system lymphoma (Review)Molecular Medicine Reports, 2009
- Pediatric primary CNS lymphoma: longterm survival after treatment with radiation monotherapyActa Neurochirurgica, 2007